CIK: 0001388325 · Show all filings
Period: Q1 2018 (← Previous) (Next →)
Filing Date: May 15, 2018
Total Value ($000): $797,426 (99.2% shares, 0.8% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INGN | INOGEN INC | 3,549,320 | $435,998 | 54.7% | $17.78 | +586.6% | COM | 45780L104 |
| — | ACCELERON PHARMA INC | 1,553,937 | $60,759 | 7.6% | $27.65 | — | COM | 00434H108 |
| — | MENLO THERAPEUTICS INC | 1,361,313 | $51,158 | 6.4% | $37.58 | — | COM | 586858102 |
| CRVS | CORVUS PHARMACEUTICALS INC | 4,420,516 | $50,969 | 6.4% | $13.03 | -27.4% | COM | 221015100 |
| — | UNUM THERAPEUTICS INC | 665,181 | $31,669 | 4.0% | $47.61 | — | COM | 903214104 |
| AKBA | AKEBIA THERAPEUTICS INC | 3,100,000 | $29,543 | 3.7% | $12.34 | +13.4% | COM | 00972D105 |
| — | MERUS N V | 1,410,417 | $26,135 | 3.3% | $7.99 | — | COM | N5749R100 |
| GKOS | GLAUKOS CORP | 565,165 | $17,424 | 2.2% | $30.14 | +0.5% | COM | 377322102 |
| — | DERMIRA INC | 1,993,746 | $15,930 | 2.0% | $30.14 | — | COM | 24983L104 |
| — | VERONA PHARMA PLC | 740,740 | $14,815 | 1.9% | $11.66 | — | SPONSORED ADS | 925050106 |
| — | NABRIVA THERAPEUTICS PLC | 2,924,822 | $14,712 | 1.8% | $10.02 | — | SHS | G63637105 |
| CRSP | CRISPR THERAPEUTICS AG | 223,317 | $10,208 | 1.3% | $18.69 | +120.8% | NAMEN AKT | H17182108 |
| KIDS | ORTHOPEDIATRICS INC | 624,591 | $9,406 | 1.2% | $18.57 | -4.6% | COM | 68752L100 |
| — | SEASPINE HLDGS CORP | 920,380 | $9,333 | 1.2% | $10.14 | — | COM | 81255T108 |
| — | RA PHARMACEUTICALS INC | 1,465,838 | $7,784 | 1.0% | $15.19 | — | COM | 74933V108 |
| — | WRIGHT MED GROUP N V | 4,622,032 | $6,332 | 0.8% | $1.25 | — | RIGHT 03/01/2019 | N96617126 |
| — | INVUITY INC | 1,363,848 | $5,251 | 0.7% | $9.51 | — | COM NEW | 46187J205 |